A pharmaceutical agent for treating and/or preventing cancer, which comprises an antibody against a cancer antigen CAPRIN-1 protein that is a protein expressed specifically on the surface of a cancer cell and an anti-tumor agent in a mixed state, separately, or in combination; and use of the pharmaceutical agent.